Growth Metrics

Plus Therapeutics (PSTV) Long-Term Investments (2024 - 2025)

Plus Therapeutics has reported Long-Term Investments over the past 6 years, most recently at $4.6 million for Q2 2025.

  • Quarterly Long-Term Investments changed N/A to $4.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Jun 2025, changed N/A year-over-year, with the annual reading at $3.5 million for FY2024, N/A changed from the prior year.
  • Long-Term Investments was $4.6 million for Q2 2025 at Plus Therapeutics, up from $3.5 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $4.6 million in Q2 2025 and troughed at $772000.0 in Q1 2024.